Amanote Research
Register
Sign In
Review: Acamprosate and Naltrexone Are Safe and Effective but Have Low Compliance Rates for People With Alcohol Dependence
Evidence-Based Mental Health
- United Kingdom
doi 10.1136/ebmh.8.1.14
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Date
February 1, 2005
Authors
G. F. Feeney
J. P Connor
Publisher
BMJ
Related search
Pharmacologically Controlled Drinking in the Treatment of Alcohol Dependence or Alcohol Use Disorders: A Systematic Review With Direct and Network Meta-Analyses on Nalmefene, Naltrexone, Acamprosate, Baclofen and Topiramate
Addiction
Medicine
Psychiatry
Mental Health
The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence, Europe Versus the Rest of the World: A Meta-Analysis
Addiction
Medicine
Psychiatry
Mental Health
Noradrenergic vs Serotonergic Antidepressant With or Without Naltrexone for Veterans With PTSD and Comorbid Alcohol Dependence
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence
CNS and Neurological Disorders - Drug Targets
Medicine
Neuroscience
Pharmacology
Are Generic Immunosuppressants Safe and Effective?
British Medical Journal
Medicine
A Systematic Review of Naltrexone for Attenuating Alcohol Consumption in Women With Alcohol Use Disorders
Alcoholism: Clinical and Experimental Research
Medicine
Psychiatry
Mental Health
Toxicology
Short Message Service (SMS) Reminders Improve Treatment Attendance in Alcohol Dependence, but Are Less Effective for Patients High in Impulsivity
Addictive Behaviors
Medicine
Clinical Psychology
Psychiatry
Mental Health
Toxicology
NEET Rates Are Substantially Higher Among Young People With Low Education
Alcohol Consumption, Alcohol Dependence and Attributable Burden of Disease in Europe: Potential Gains From Effective Interventions for Alcohol Dependence
